Publications
126
Citations
2,508
Est. group size
~13
Recurring co-author estimate
Active years
32
Publishing since 1995
Typically publishes in teams of ~4 · 34% small-team papers (≤3 authors) · across 20 venues
- Synthesis of Bufadienolide Natural Products and Analogs via Singlet Oxygen Oxidation and Late-Stage Modification
The Journal of Organic Chemistry · 2026
- Stereoelectronic Effect of Protecting Groups on the Stability of Galactosyl Donor Intermediates
Molecules · 2025
- Total Syntheses of Bufadienolide Natural Products and Analogs via Singlet Oxygen Oxidation and Late-Stage Modification
ChemRxiv · 2025
- Synthesis of Chiral Aziridine Ligands for Asymmetric Alkylation with Alkylzincs: Diphenyl(( <i>S</i> )‐1‐(( <i>S</i> )‐1‐phenylethyl)aziridin‐2‐yl)methanol
Organic Syntheses · 2025
- Selective (α)- <scp>l</scp> -Rhamnosylation and Neuroprotective Activity Exploration of Cardiotonic Steroids
ACS Medicinal Chemistry Letters · 2024
- Update on a brain-penetrant cardiac glycoside that can lower cellular prion protein levels in human and guinea pig paradigms
PLoS ONE · 2024
- Selective (a)-L-Rhamnosylation and Neuroprotective Activity Exploration of Cardiotonic Steroids
ChemRxiv · 2024
- New strategies for diversifying steroidal scaffold to generate b17-heterocycle-substituted derivatives from a common readily accessible intermediate
ChemRxiv · 2024
- Development of Recyclable Polystyrene-Supported Phosphonic Acid Resins for Carbohydrate Immobilization and Glycosylation
The Journal of Organic Chemistry · 2023
- Synthesis of (((1 <i>R</i> ,3 <i>S</i> ,3′ <i>S</i> )‐3,3′‐Diethyl‐3 <i>H</i> ,3′ <i>H</i> ‐1,1′‐spirobi[isobenzofuran]‐7,7′‐diyl)bis(oxy))bis(diphenylphosphane)
Organic Syntheses · 2023
- Electrochemical Synthesis of Glycosyl Fluorides Using Sulfur(VI) Hexafluoride as the Fluorinating Agent
Organic Letters · 2022
- Identification of a Cardiac Glycoside Exhibiting Favorable Brain Bioavailability and Potency for Reducing Levels of the Cellular Prion Protein
International Journal of Molecular Sciences · 2022
- Identification of a cardiac glycoside exhibiting favorable brain bioavailability and potency for reducing levels of the cellular prion protein
bioRxiv (Cold Spring Harbor Laboratory) · 2022
- (11b <scp> <i>R</i> </scp> )‐4‐Hydroxy‐2,6‐bis[2,4,6‐tris(1‐methylethyl)phenyl]‐dinaphtho[2,1‐ <scp> <i>d</i> </scp> :1′,2′‐ <scp> <i>f</i> </scp> ][1,3,2]dioxaphosphepin‐4‐oxide, [( <scp> <i>R</i> </scp> )‐ <scp>TRIP</scp> ] & (11b <scp> <i>S</i> </scp> )‐4‐Hydroxy‐2,6‐bis[2,4,6‐tris(1‐methylethyl)phenyl]‐dinaphtho[2,1‐ <scp> <i>d</i> </scp> : 1′,2′‐ <scp> <i>f</i> </scp> ][1,3,2]dioxaphosphepin‐4‐oxide, [( <scp> <i>S</i> </scp> )‐TRIP]
Encyclopedia of Reagents for Organic Synthesis · 2022
- Synthesis and Evaluation of C2-Symmetric SPIROL-Based bis-Oxazoline Ligands
Symmetry · 2021
- ChemRxiv×16
- The Cambridge Structural Database×11
- Organic Letters×7
- Journal of the American Chemical Society×4
- Angewandte Chemie International Edition×3
- Girish C. Sati
Chemistry · University of Michigan
- Yashapal Singh
Chemistry · Purdue University West Lafayette
- Robert Barker
Chemistry · Purdue University West Lafayette
- Christopher S. Callam
Chemistry · The Ohio State University
- Eunice Lee
Chemistry · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile